Skip to main content
Year archive

Biotest AG — 2025 filings

All 34 regulatory filings released by Biotest AG (BIO3) in 2025, sourced directly from the official regulator.

34 Filings
2025 Period
2025 filings (34)
Filing Released Lang
Biotest announces US FDA approval of Grifols FesiltyTM (fibrinogen, human-chmt)
Regulatory Filings
2025-12-19 English
§§ 264 Abs. 3, 264b HGB zum Geschäftsjahr vom 01.01.2025 bis zum 31.12.2025
Audit Report / Information FY 2025
2025-12-01 German
Biotest obtains approval for new human fibrinogen Prufibry in Germany
Regulatory Filings
2025-11-13 English
Biotest AG: Extraordinary general meeting convened again at the request of Grifols S.A.
AGM Information
2025-11-07 English
Biotest AG: Cancellation of the extraordinary general meeting on 28 October 2025
AGM Information
2025-10-23 English
Biotests Yimmugo launches in the United States
Regulatory Filings
2025-10-09 English
Biotest AG: Extraordinary general meeting convened at the request of Grifols S.A.
AGM Information
2025-09-19 English
Articles of association - as of July 02, 2025
AGM Information
2025-09-17 English
Jahresabschluss zum Geschäftsjahr vom 01.01.2024 bis zum 31.12.2024
Notice of Dividend Amount
2025-08-06 German
Biotest AG receives a request from Grifols S.A. to convene an extraordinary general meeting
Legal Proceedings Report
2025-08-04 English
Biotest AG: Annual General Meeting approves dividend distribution
AGM Information
2025-07-02 English
Biotests positive fibrinogen phase III trial results published in The Lancets eClinicalMedicine
Regulatory Filings
2025-06-23 English
Berichtigung der Veröffentlichung vom 17.04.2025
Audit Report / Information FY 2024
2025-06-20 German
Biotest AG: Delisting of Biotest shares from the Frankfurt Stock Exchange with effect from 6 June 2025
Delisting Announcement
2025-06-03 English
Biotest AG: Change of the Chief Executive Officer (CEO) of Biotest AG
Board/Management Information
2025-05-28 English
Biotest confirms Guidance for 2025
Earnings Release Q1 2025
2025-05-12 English
Q1 statement / Q1 financial report 2025
Interim / Quarterly Report Q1 2025
2025-05-12 English
Bericht zur Gleichstellung und Entgeltgleichheit nach EntgTranspG als Anlage des Lageberichts zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
Remuneration Information
2025-05-05 German
Berichtigt am 17.06.2025
Annual Report (ESEF) FY 2024
2025-04-16 German
Biotest AG increases sales by 6% in financial year 2024
Earnings Release FY 2024
2025-03-31 English
Annual financial report 2024
Annual Report FY 2024
2025-03-31 English
Remunerations Report 2024
Audit Report / Information FY 2024
2025-03-24 English
Biotest AG: CFO Martin Moller to leave Biotest as planned at the end of his contract. Position of CFO to be filled in the near future.
Board/Management Information
2025-03-06 English
declaration of compliance 2025
Governance Information
2025-03-05 English
Management declaration 2025 ($ 315d HG and §289f HGB)
Governance Information
2025-03-05 English
Report Publication Announcement 2025
Report Publication Announcement
2025-02-28 English
Biotest AG publishes preliminary business figures - 2024 forecasts partially exceeded
Earnings Release FY 2024
2025-02-27 English
Hinweis auf Halbjahresfinanzbericht vom 01.01.2025 bis zum 30.06.2025
Report Publication Announcement
2025-02-27 German
Hinweis auf Konzernabschluss vom 01.01.2024 bis zum 31.12.2024
Report Publication Announcement
2025-02-27 German
Hinweis auf Jahresfinanzbericht vom 01.01.2024 bis zum 31.12.2024
Report Publication Announcement
2025-02-27 German
Hinweis auf Halbjahresfinanzbericht vom 01.01.2025 bis zum 30.06.2025
Report Publication Announcement
2025-02-27 German
Biotest AG publishes preliminary business figures - 2024 forecasts partially exceeded
Earnings Release FY 2024
2025-02-26 English
Important milestone for Biotest: Biologics License Application for Fibrinogen submitted to the US Food and Drug Administration (FDA)
Regulatory Filings
2025-01-10 English
Important milestone for Biotest: Biologics License Application for Fibrinogen submitted to the US Food and Drug Administration (FDA)
Regulatory Filings
2025-01-09 English